• Next generation adenovirus vector

    Next generation adenovirus vector

    Empowering Immune Boosting, Oncolytic Cancer
    Treatments, Gene Delivery and CRISPR/Cas9 Treatments

    Read more
  • bildspel-cd70-1

    The cd70 platform

    Enabling Superior Expansion and Longevity of Tumor Specific CAR T-Cells for adoptive immunotherapy

    Read more
  • The combig platform

    Meet our COMBIG-platform

    Enabling off-the-shelf, cell-based cancer
    immune primers for personalized treatment

    Read more

Immunicum is listed on NASDAQ OMX First North Premier under the ticker IMMU.

About us

Developing innovative cancer immunotherapies

We are on a journey towards the world’s first patient unique, off-the-shelf cancer treatment. Get to know the technology that will take us there.

Learn more